ESC 365 - SGLT2 Inhibitor related polycythaemia: a potential severe side effect.

HFA Premium Access

SGLT2 Inhibitor related polycythaemia: a potential severe side effect.

Session: Chronic heart failure 1

Topic: Chronic Heart Failure

Speaker: Mr M. Tukker (Rotterdam, NL)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Mr Martijn Tukker

Rotterdam (Netherlands (The))

1 presentation

0 follower

4 more presentations in this session

Patent ductus arteriosus: an unexpected diagnosis at the adulthood

Speaker: Doctor F. Duarte (Ponta Delgada, PT)

Cardiotoxicity? Systematic sclerosis? in quest of answers.

Speaker: Doctor P. Kourkoveli (Maroussi-Athens, GR)

Monitoring of volume status using a novel sensor for the assessment of inferior vena cava area and collapsibility in a patient with HFrEF receiving advanced heart failure therapy a case study.

Speaker: Professor F. Malek (Prague, CZ)

Measuring the Acute Effects of Cardiac Contractility Modulation (CCM) Therapy with a Non-Invasive Bioimpedance Hemodynamic System (NICaS)

Speaker: Doctor A. Madeo (Castrovillari, IT)

Access the full session

Chronic heart failure 1

Speakers: Mr M. Tukker, Doctor F. Duarte, Doctor P. Kourkoveli, Professor F. Malek, Doctor A. Madeo

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources